HOUSTON, Feb. 20, 2024 /PRNewswire/ -- FibroBiologics (Nasdaq: FBLG) ("FibroBiologics") is a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development ...
ORLANDO, FL / ACCESS Newswire / September 8, 2026 / RedChip Companies will host an investor webinar on Tuesday, September 22, 2026, at 4:15 p.m. ET with FibroBiologics, Inc. (NASDAQ:FBLG). The ...
FibroBiologics, Inc. Announces Investor Webinar on Innovative Fibroblast-Based Cell Therapy Platform
FibroBiologics, Inc., a clinical-stage biotechnology company focused on developing therapies for chronic diseases through fibroblasts, announced an investor webinar scheduled for July 10, 2025, at ...
NEW YORK (PIX11) – It is being called a game-changer in curing some of the world’s most crippling diseases and conditions. Technology developed by FibroBiologics is already proving in small trials to ...
Discusses Strategy and Clinical Progress in Fibroblast-Based Cell Therapies for Chronic Diseases September 22, 2026 4:15 ...
ORLANDO, FL / ACCESS Newswire / September 8, 2026 / RedChip Companies will host an investor webinar on Tuesday, September 22, 2026, at 4:15 p.m. ET with FibroBiologics, Inc. (NASDAQ:FBLG). The ...
FibroBiologics receives US patent for the therapeutic use of fibroblasts in wound healing: Houston Saturday, September 5, 2026, 11:00 Hrs [IST] FibroBiologics, Inc., a clinical-st ...
Learn how FibroBiologics is developing an off-the-shelf therapeutic platform designed to harness the regenerative and immune-modulating properties of fibroblasts Management to discuss the ongoing ...
Learn how FibroBiologics is developing an off-the-shelf therapeutic platform designed to harness the regenerative and immune-modulating properties of fibroblasts Management to discuss the ongoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results